Ensuring Integrity in use of 340B pricing: Responsibility, Compliance, Accountability



Similar documents
The 3 Keys to Success in Your 340B Program. Rob Nahoopii, PharmD, MS, BCPS CEO Turnkey Pharmacy Solutions A 340B Management Company

Keep Your Savings: 340B Audits and Ensuring Compliance

TEXAS VENDOR DRUG PROGRAM PHARMACY PROVIDER PROCEDURE MANUAL

340B University Page 1 340B Manager and Coordinator Job Description Template

340B University Page 1 Split-Billing Software Considerations Checklist

10/1/2013. Objectives. 340B Drug Pricing Program; Transitioning from Access to Integrity. 340B Stats, Arkansas. 340B Participating Entities, AR

an analysis of 340B solutions a white paper by Michael J. Sovie, Pharm.D., MBA

340B Drug Discount Program Improving Compliance to Protect Savings and Be Audit Ready. Suzanne Herzog Founding Director Rx X Consulting

340B Drug Pricing Program

340B Drug Pricing Program January 15, 2015

340B Drug Discount Program Overview and Emerging Issues

340B Drug Pricing Program 340B Contract Pharmacy

340B Compliance: I sure wish I d known that!

Printed copies are for reference only. Please refer to the electronic copy of this policy for the latest version.

340B Compliance Self-Assessment: Self-Audit Process Page 1 A Sample Self-Audit Process for Community Health Centers

B & Prime Vendor Program Update

Federal 340B Drug Pricing Program

Finally... maybe? The Long Awaited 340B Mega Guidance. Georgia Healthcare Financial Management Association. October 2015

340B UNIVERSITY Las Vegas Edition. May 31, 2014

340B Drug Discount Program Identifying risks and internal audit focus areas

4/3/2015 WHAT IS 340B? DISCLOSURE. No conflicts of interest to disclose

The Pharmacy 340B Program- Compliance & Internal Audit Strategies. for Covered Entities. Matthew D. Vogelien Huron Healthcare

(RIN) 0906-AB08; 340-B

Legal Alert. Long-Awaited 340B Program Guidance Now Available for Comments: What Stakeholders Need to Know. Authors

HRSA Pharmacy Services Support Center: The 340B Access Resource

340B Drug Pricing Program: Recent Developments and Compliance Update

340B: ARE WE MONITORING COMPLIANCE EFFECTIVELY AND EFFICIENTLY

Jennifer Agee Manager Pharmacy System Legacy Health

340B PROGRAM. Scrutiny & Uncertainty Increase the Need for Compliance

340B Drug Pricing Program: Overview and Recent Developments

340B DISCOUNT DRUG PROGRAM OVERVIEW

CPAs and ADVISORS. experience access // 340B QUALIFICATIONS, BENEFITS AND CURRENT FOCUS

XXXXXXXFUNDAMENTALS An Essential Guide for Health System Executive Management

Medical Care Advisory Committee. Andy Vasquez, Deputy Director, Medicaid/CHIP Vendor Drug Program Health and Human Services Commission

Medicaid and 340B. Presentation to: GHA 340B Day Presented by: Linda Wiant, Pharm.D. Pharmacy Director. Date:

SECTION 12 - REIMBURSEMENT METHODOLOGY

340B DRUG DISCOUNT PROGRAM OMNIBUS GUIDANCE. Presented by the American Bar Association Health Law Section and Center for Professional Development

The 340B Program: Today and Beyond

340B Policy Landscape

340B Mega Guidance: Implications for Essential Hospitals Sarah Mutinsky and Barbara Eyman Washington Counsel, America s Essential Hospitals Eyman

C. Covered 340B drugs, as found in section 1927 (k)(2) of the Social Security Act, include the following outpatient drugs:

2015 Annual Convention

Maximizing the 340B Drug Discount Program: A Webinar for Finance Executives in 340B Hospitals Webinar

Leveraging Star Ratings in Medicare Within Community Pharmacies

Is your organization 340B equipped? Understanding Contract Pharmacy arrangements

Pharmacy Benefit Managers: What we do

Real-time Pre and Post Claim Edits: Improve Reimbursement, Compliance and Safety

Best Practices. How to Approach the State for Medicaid Dispute Resolution

June G. Javier, PharmD, BCPS Friday, April 17, 2015

The 340B Drug Pricing Program: The Basics INTEGRITY ACCESS VALUE 1

DSH Litigation and 340B Program Update: What Participating Hospitals Need to Know and What They Should Be Doing

The 340B Program: New Developments and New Opportunities for CAHs and Others. Todd Nova Hall Render

An Update on Acquisition Cost Based Reimbursement Models. Jerry Brehany, PharmD, PA-C, JD AVP Pharmacy Services

Inventory Management. Statement of Conflicts of Interest. Today s Goals 1/29/2014

340B UNIVERSITY San Francisco Edition. February 3-4, 2015

MAPD-SNP Contract Numbers: H5852; H3132

Implementing a System-wide 340B Program

Documentation, coding, charging, and billing for medications Identifying risks and internal audit focus areas

CMS Pharmacy Update Part 1. Current Medicaid Issues

GAO DRUG PRICING. Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs Improvement

340B and the Pharmacy Wholesaler s Role

Adopting an EHR & Meaningful Use

The 340B Drug Pricing Program: The Basics

Introduction. Plan sponsors include employers, unions, trust funds, associations and government agencies, and are also referred to as payors.

Members covered under the Extended Family Planning (EFP) plan may not be eligible for all services. EFP is not a comprehensive benefit package.

Brief Summary of the National Physician Payment Transparency Program: Open Payments Physician Payment Sunshine Act

PHYSICIAN-ADMINISTERED MEDICATION: BILLING REQUIREMENTS

Specialty Pharmacy? Disclosure. Objectives Technician

Overview of Drug Pricing for Public Programs

When Public Payment Declines, Does Cost-Shifting Occur? Hospital and Physician Responses. November 13, 2002 Washington, DC

Will the ASP data submitted to CMS be releasable to the public?

Natalie Pons, Senior Vice President, Assistant General Counsel, Health Care Services. CVS Caremark Corporation

Faculty Disclosure. Pharmacist Learning Objectives. Pharmacy e-hit: The Future of Pharmacy and Patient Care

NAMD WORKING PAPER SERIES. Medicaid and the 340B Program: Alignment and Modernization Opportunities

STATES COLLECTION OF REBATES FOR DRUGS PAID THROUGH MEDICAID MANAGED CARE ORGANIZATIONS

Jason Mills, PharmD, MBA Pharmacy Supply Chain Manager Medical University of South Carolina

Inpatient EHR. Solution Snapshot. The right choice for your patients, your practitioners, and your bottom line SOLUTIONS DESIGNED TO FIT

I m awash in reports, how do I access clear information? Sentry Data Systems Saves You Time and Money

October 27, Attention: RIN 0906-AB08. RE: 340B Drug Pricing Program Omnibus Guidance. Dear Captain Pedley:

Transcription:

Ensuring Integrity in use of 340B pricing: Responsibility, Compliance, Accountability Fern Paul-Aviles, PharmD, MS, BCPS Director, 340B and Ambulatory Regulatory Program Compliance Carolinas Healthcare System

The 340B Federal Drug Discount Program: Responsibility, Accountability, and Compliance Fern Paul-Aviles, Pharm.D., M.S., B.C.P.S., Pharmacy Manager, Carolinas Medical Center Clinic Pharmacies ACPE #: 207-999-13-029-L04-P Activity Type: Knowledge-based Following this presentation, attendees should be able to: 1. List the major 340B compliance components. 2. Describe the key personnel responsible for compliance with the 340B program and their roles. 3. Describe the process for addressing 304B policy and for maintenance of integrity of 340B program participation. 4. Outline areas where technology could assist in compliance with the 340B program.

Disclosures Fern Paul-Aviles declares no conflicts of interest or financial interest in any product or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria. ASAP s and NCPA s education staff declares no conflicts of interest or financial interest in any product or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria.

List the major 340B compliance components Review the key personnel responsible for compliance with the 340B program and their roles Describe the process for addressing 304B policy and for maintenance of integrity of 340B program participation Outline areas where technology could assist in compliance with the 340B program

Responsibility Compliance Accountability

Intent was to stretch scarce health care resources, not to save patients money Only outpatient care areas are eligible Outpatient clinics & pharmacies ED & Obs, One-Day Surgery, Endoscopy General Acctg Off report recommendations Audits Finalize new, more specific guidance on the definition of a 340B patient July 18, 2012

Major compliance areas Patient definition: Patient must be cared for in a hospital outpatient area AND The physician caring for the patient must be employed or contracted by the hospital; AND The hospital must own the pt s medical record Meds must be for a condition the HC is treating Duplicate discounts Since the mfr has given the covered entity a discount up-front, it is the covered entity s responsibility to ensure that Medicaid does not ask for a rebate on the back end GPO exclusion Drugs bought for use in 340B-eligible areas cannot be purchased using GPO-negotiated pricing 7

Major Compliance Areas Patient definition Locations of hospital outpatient areas: Must be on reimbursable lines of hospital s Medicare cost report, lines 50-118 of 2011 version Create lists of eligible clinics if screening manually Patient registration (eligibility) Need a time-stamp the actual time of admission to an inpatient area (or discharge then re-admit) Differentiate between patient indicator and service date patient type when pulling reports Utility of eligible patient file - HC

9 Major compliance areas Duplicate discounts Avoidance of duplicate discounts Easy in retail pharmacies Hard to avoid when there is more than one type of billing at a given covered entity (e.g. retail pharmacies and hospital mixed-use setting) Harder to avoid in hospital mixed-use settings States handling of duplicate discount provision States differ on use of OPA s Medicaid Exclusion file Some states require billing at actual acquisition cost Some states require UD modifiers on claims to signify to Medicaid that drugs were purchased at 340B prices

10 Major compliance areas GPO exclusion Difficult to avoid with split-billing methodology Hospital pharmacies have existing GPO accounts before enrolling in 340B

Compliant 340B In Mixed-Use Areas Mixed-Use Inventory Drug Order Drug Administration Accumulator Inpatient GPO WAC 340B

Required involved parties Hospital-wide committee C-Suite (CEO, COO, CFO, etc.) Savings projections are difficult Evaluate savings vs. investment Corporate Compliance or Internal Audit Director of Hospital Reimbursement/Finance Patient registration/access Information Services Utilization reports pulled for eligible areas Spreadsheet with hospital outpatient areas Wholesaler Correct account set-up Pharmacy chargemaster - mapping from charge item to NDC # Pharmacy Buyer - override wholesaler generic programs

Where can technology help? Split-billing Extraction of utilization data (patient definition) Maximization identifying all eligible patients Compliance identifying only eligible patients Savings reports Alerts No data in utilization file No product in wholesaler system No product in hospital computer system (virtual inventory) No invoices uploaded Negative accumulation for specific NDC Wide discrepancy between dispenses and purchases Contract pharmacies Enrollment files vs eligibility testing through registration system Creation of invoices

Responsibility Compliance Accountability

Self-assessment questions Which of these is the only determinant of whether an area of the hospital is 340B-eligible? Billing is done via facility billing (CMS 1500/837p submission) Because your Finance person wants to believe it is so It is on the reimbursable lines of the hospital s cost report Because the patients who are served there are indigent and the practice agreed to care for them Which of the following key stakeholders are responsible for compliance with the 340B programs? The 340B entity The vendor of split-billing software The wholesaler The contract pharmacy All of the above Which program of the Office of Pharmacy Affairs is intended to prove the value of clinical pharmacist activities? PSPC (Patient Safety and Clinical Pharmacy Collaborative) 340B program Annual recertification 15

Self-assessment ANSWERS Which of these is the only determinant of whether an area of the hospital is 340B-eligible? Billing is done via facility billing (CMS 1500/837p submission) Because your Finance person wants to believe it is so It is on the reimbursable lines of the hospital s cost report Because the patients who are served there are indigent and the practice agreed to care for them Which of the following key stakeholders are responsible for compliance with the 340B programs? The 340B entity The vendor of split-billing software The wholesaler The contract pharmacy All of the above Which program of the Office of Pharmacy Affairs is intended to prove the value of clinical pharmacist activities? PSPC (Patient Safety and Clinical Pharmacy Collaborative) 340B program Annual recertification 16